ABSTRACT
ABSTRACT: Background: Active abdominal compression-decompression cardiopulmonary resuscitation (AACD-CPR) is potentially more effective for cardiac arrest (CA) with multiple rib fractures. However, its effect on survival rates and neurological outcomes remains unknown. This study aimed to assess if AACD-CPR improves survival rates and neurological outcomes in a rat model of asphyctic CA with multiple rib fractures. Methods: Adult male Sprague-Dawley rats were randomized into three groups-AACD group (n = 15), standard cardiopulmonary resuscitation (STD-CPR) group (n = 15), and sham group (n = 10)-after bilateral rib fractures were surgically created and endotracheal intubation was performed. AACD-CPR and STD-CPR groups underwent 8 min of asphyxia followed by different CPR techniques. The sham group had venous catheterization only. Physiological variables and arterial blood gases were recorded at baseline and during a 4-h monitoring period. Neurological deficit scores (NDSs) and cumulative survival rates were assessed at 24, 48, and 72 h. NDS, serum biomarkers, and hippocampal neuron analysis were used to evaluate neurological outcomes. Results: No statistical differences were observed in the return of spontaneous circulation (ROSC), 24-, 48-, and 72-h survival rates between the AACD-CPR and STD-CPR groups. AACD-CPR rats had lower serum levels of neuron-specific enolase and S100B at 72 h post-ROSC, and higher NDS at 72 h post-ROSC compared with STD-CPR animals. Cellular morphology analysis, hematoxylin and eosin staining, and TUNEL/DAPI assays showed more viable neurons and fewer apoptotic neurons in the AACD-CPR group than in the STD-CPR group. Conclusions: AACD-CPR can achieve similar survival rates and better neurological outcome after asphyxial CA in rats with multiple rib fractures when compared with STD-CPR.
Subject(s)
Cardiopulmonary Resuscitation , Heart Arrest , Rib Fractures , Animals , Rats , Male , Cardiopulmonary Resuscitation/methods , Asphyxia/therapy , Rib Fractures/complications , Rib Fractures/therapy , Rats, Sprague-Dawley , Heart Arrest/therapy , Lower Body Negative PressureABSTRACT
We conducted a retrospective study to identify the risk factors for pneumonia in hospitalized pediatric patients with influenza B infection. Receiving oseltamivir within the first 48 hours of onset and frequent cough was respectively considered as a protective factor and a risk factor for the influenza B virus-associated pneumonia in hospitalized pediatric patients. Early administration of oseltamivir can reduce the risk of influenza B virus-associated pneumonia.
Subject(s)
Antiviral Agents/administration & dosage , Influenza B virus/drug effects , Orthomyxoviridae Infections/complications , Orthomyxoviridae Infections/virology , Oseltamivir/administration & dosage , Pneumonia, Viral/etiology , Pneumonia, Viral/prevention & control , Adolescent , Child , Child, Preschool , Female , Hospitalization , Humans , Infant , Infant, Newborn , Male , Orthomyxoviridae Infections/diagnosis , Orthomyxoviridae Infections/drug therapy , Post-Exposure Prophylaxis , Retrospective Studies , Time-to-Treatment , Treatment OutcomeABSTRACT
BACKGROUND: There is limited knowledge regarding the risk factors for influenza B virus-associated pneumonia in adults. This study aimed to determine the risk factors for influenza B virus-associated pneumonia in adults. METHODS: We used viral surveillance data during the pandemic season between November 2017 and April 2018 from the University of Hong Kong-Shenzhen Hospital medical record database. The files of patients ages 18 years or older were reviewed for demographics, clinical characteristics, laboratory findings, and outcome. Multivariate logistic regression analysis was performed to identify risk factors associated with influenza B virus-associated pneumonia. RESULTS: A total of 78 patients with influenza B, ages 20 to 87 years, were identified. Comparing cases with pneumonia vs cases without pneumonia, there were significant differences in the following: age in years (67.41 ± 16.63 vs 58.16 ± 17.65; Pâ¯=â¯.028), age group (74.1% vs 51.0%; Pâ¯=â¯.049), chronic respiratory diseases (70.4% vs 21.6%; Pâ¯=â¯.000), shortness of breath (40.7% vs13.7%; Pâ¯=â¯.007), abnormal breath sounds on auscultation (51.9% vs 21.6%; Pâ¯=â¯.006), and serum alanine transaminase level (30.07 ± 10.73 vs 38.64 ± 21.68; Pâ¯=â¯.022). Logistic regression models indicated that chronic respiratory diseases (odds ratio, 8.452; 95% confidence interval, 2.768-25.808; Pâ¯=â¯.000) and shortness of breath (odds ratio, 1.261; 95% confidence interval, 1.015-1.566; Pâ¯=â¯.036) were independent risk factors. CONCLUSIONS: This study suggests that chronic respiratory diseases and shortness of breath are independent risk factors for influenza B virus-associated pneumonia in adult patients.
Subject(s)
Influenza B virus , Influenza, Human/complications , Influenza, Human/virology , Pneumonia/etiology , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Pneumonia/pathology , Young AdultABSTRACT
BACKGROUND AND OBJECTIVE: Invasive pulmonary aspergillosis (IPA) remains a life-threatening infection in patients with prolonged neutropenia. Few data are available on IPA in non-neutropenic patients without underlying immunocompromising conditions. METHODS: All non-neutropenic patients managed at the institution for a proven and probable IPA over the last 10 years were reviewed retrospectively, and the difference between non-neutropenic patients with and without underlying disease was investigated. RESULTS: Among 52 cases of IPA analysed here, 33 were histologically proven; 19 were probable. Forty-two (80.8%) patients had underlying diseases; 10 (19.2%) patients had no any underlying diseases. There is a significant difference in seasonal distribution among patients with underlying conditions (P = 0.026), but no seasonal difference was found in the other group (P = 0.622). The only significant difference in symptoms between the two groups was fever (P = 0.015). Radiological findings were non-specific in the two groups. Despite treatment, the overall crude mortality rate among 52 patients was 39%. The overall mortality rate in patients with underlying disease was 45%, while that in patients without underlying conditions was 11%. A Cox multivariate analysis showed that organ failure (hazard ratios: 8.739, 95% CI: 3.770-20.255; P = 0.000) was independently associated with overall mortality. CONCLUSIONS: Clinical features of IPA are not well known in non-neutropenic patients, especially in those without underlying conditions. In this study, organ failure was associated with a lower rate of survival of non-neutropenic patients with IPA.